Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.05 - LIBRETTO-431: Selpercatinib in Treatment-Naïve Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).
00:00 - 00:00 | Presenter: Koichi Goto
- Abstract
Loading... -
+
FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC
00:00 - 00:00 | Presenter: Herbert H Loong
- Abstract
Loading...
-
+
P02 - Diagnostics and Interventional Pulmonology
- Type: Posters
- Track: Diagnostics and Interventional Pulmonology
- Presentations: 25
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P02.03 - Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.
00:00 - 00:00 | Presenter: Tetsuya Sakai
- Abstract
Loading...
-
+
P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 8
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P15.03 - A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC
00:00 - 00:00 | Presenter: Koichi Goto
- Abstract
Loading...
-
+
P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 22
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P75.01 - Activity of Brigatinib in Alectinib-Resistant ALK-Positive NSCLC According to ALK Plasma Mutation Status From J-ALTA Trial
00:00 - 00:00 | Presenter: Toyoaki Hida
- Abstract
Loading...
-
+
P89 - Targeted Therapy - Clinically Focused - Translational
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P89.06 - Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer
00:00 - 00:00 | Presenter: Shingo Matsumoto
- Abstract
Loading...
-
+
IS04 - Industry Symposium Sponsored by Lilly Oncology: Implementing Precision Oncology in the Clinic: Diagnostic Challenges and Best Practices
- Type: Industry Symposium
- Track:
- Presentations: 7
- Coordinates: 1/28/2021, 13:00 - 14:00, Industry Symposia Auditorium (via Industry Hub)
-
+
IS04.01 - Chair’s Welcome
13:00 - 13:04 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS04.02 - Introduction to the Topic - A Brief Overview of the 15-Year Journey of Biomarker Driven Management of NSCLC
13:04 - 13:10 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS04.07 - Symposium Close
14:00 - 14:00 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
OA04 - New Data from Rare EGFR Alterations
- Type: Oral
- Track: Targeted Therapy - Clinically Focused
- Presentations: 8
- Coordinates: 1/29/2021, 11:45 - 12:45, Scientific Program Auditorium
-
+
OA04.04 - Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer
11:55 - 12:05 | Presenter: Joshua K. Sabari
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies
- Type: Industry Symposium
- Track:
- Presentations: 4
- Coordinates: 1/30/2021, 13:00 - 14:00, Industry Symposia Auditorium (via Industry Hub)
-
+
IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC
13:20 - 13:40 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS15 - Industry Symposium Sponsored by Amoy: Lung Cancer Biomarker Panel Testing
- Type: Industry Symposium
- Track:
- Presentations: 5
- Coordinates: 1/31/2021, 13:00 - 14:00, Industry Symposia Auditorium (via Industry Hub)
-
+
IS15.03 - Biomarker Panel Testing: PCR Panel vs NGS Panel
13:21 - 13:39 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
MA11 - Expanding Targetable Genetic Alterations in NSCLC
- Type: Mini Oral
- Track: Targeted Therapy - Clinically Focused
- Presentations: 12
- Coordinates: 1/31/2021, 14:15 - 15:15, Scientific Program Auditorium
-
+
MA11.02 - Chair
14:15 - 14:15 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
